Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

CIK: 0001703031 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value ($000): $591,296 (100.0% shares, 0.0% debt)

Holdings (11)

— SPRINGWORKS THERAPEUTICS INC 33.2%

Value ($000) $196,595 Shares 7,281,307 Est. Cost $21.68 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS, INC. 20.1%

Value ($000) $118,583 Shares 3,979,292 Est. Cost $26.87 Unrealized 0.0%

— DICERNA PHARMACEUTICALS INC 12.7%

Value ($000) $74,954 Shares 4,080,237 Est. Cost $9.03 Unrealized —

— CONSTELLATION PHARMACEUTICALS INC. 11.7%

Value ($000) $69,257 Shares 2,203,529 Est. Cost $47.11 Unrealized —

— DYNAVAX TECHNOLOGIES CORP. 5.2%

Value ($000) $30,819 Shares 8,730,707 Est. Cost $3.58 Unrealized —

REPL REPLIMUNE GROUP INC 4.8%

Value ($000) $28,305 Shares 2,838,968 Est. Cost $17.53 Unrealized -15.0%

SVRA SAVARA INC 3.9%

Value ($000) $22,976 Shares 5,128,593 Est. Cost $1.20 Unrealized +127.8%

— X4 PHARMACEUTICALS INC 2.8%

Value ($000) $16,485 Shares 1,648,485 Est. Cost $10.70 Unrealized —

— MARINUS PHARMACEUTICALS INC 2.0%

Value ($000) $12,064 Shares 5,942,735 Est. Cost $6.30 Unrealized —

— APTINYX INC 2.0%

Value ($000) $12,006 Shares 5,558,425 Est. Cost $10.97 Unrealized —

— SOLID BIOSCIENCES INC 1.6%

Value ($000) $9,252 Shares 3,871,164 Est. Cost $8.88 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SPRINGWORKS THERAPEUTICS INC	7,281,307	$196,595	33.2%	$21.68	—	COM	85205L107
ARQT	ARCUTIS BIOTHERAPEUTICS, INC.	3,979,292	$118,583	20.1%	$26.87	0.0%	COM	03969K108
—	DICERNA PHARMACEUTICALS INC	4,080,237	$74,954	12.7%	$9.03	—	COM	253031108
—	CONSTELLATION PHARMACEUTICALS INC.	2,203,529	$69,257	11.7%	$47.11	—	COM	210373106
—	DYNAVAX TECHNOLOGIES CORP.	8,730,707	$30,819	5.2%	$3.58	—	COM	268158201
REPL	REPLIMUNE GROUP INC	2,838,968	$28,305	4.8%	$17.53	-15.0%	COM	76029N106
SVRA	SAVARA INC	5,128,593	$22,976	3.9%	$1.20	+127.8%	COM	805111101
—	X4 PHARMACEUTICALS INC	1,648,485	$16,485	2.8%	$10.70	—	COM	98420X103
—	MARINUS PHARMACEUTICALS INC	5,942,735	$12,064	2.0%	$6.30	—	COM	56854Q101
—	APTINYX INC	5,558,425	$12,006	2.0%	$10.97	—	COM	03836N103
—	SOLID BIOSCIENCES INC	3,871,164	$9,252	1.6%	$8.88	—	COM	83422E105